Vol. 18 No. 3 (2024): Revista Reumatología al Día
Reportes de Casos Clínicos

Adult-onset Still's disease (AOSD), a diagnostic challenge. Case report

Nora Alarcón Cedeño
Servicio de Alergología e Inmunología, Hospital General Portoviejo, Manabí, Ecuador
Yelena Sánchez Cantos
Hospital General Portoviejo
Amada Barcia Cansino
Hospital General Portoviejo

Published 2024-12-24

Keywords

  • Still's disease,
  • ferritin,
  • fever

How to Cite

Alarcón Cedeño, N., Sánchez Cantos, Y., & Barcia Cansino, A. (2024). Adult-onset Still’s disease (AOSD), a diagnostic challenge. Case report. Reumatología Al Día, 18(3), 6. https://doi.org/10.62484/rad.v18i3.9259

Abstract

Adult Still's disease (ASD) is a rare medical condition with rare Adult-onset Still's disease (AOSD) is a rare inflammatory disease of unknown etiology, with varied clinical presentation and symptoms such as fever, evanescent salmon rash, odynophagia, lymphadenopathy, hepatosplenomegaly, leukocytosis (neutrophilia), hyperferritinemia associated with the absence of antibodies. We present the case of a female patient who presented typical and atypical symptoms. Initial laboratory studies reported increased acute phase reactants, considering infectious, neoplastic and autoimmune processes as differential diagnosis. Multidisciplinary pharmacological treatment was indicated with satisfactory discharge results after 25 days of hospitalization, with institutional limitations for obtaining laboratories, concluding that Still's disease remains a diagnostic challenge for the physician since we do not have a specific diagnostic test and Yamaguchi' criteria can be a guide for its early diagnosis.

Metrics

Metrics Loading ...

References

  1. Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld. A comprehensive review on adult-onset Still's disease. Journal of Autoimmunity Volumen 93, September 2018, Pages 24-36
  2. Petros Efthimiou, Apostolos Kontzias, Peter Hur, Kavita Rodha, G S Ramakrishna, Priscila Nakasato. Adult-onset Still’s disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Seminars in Arthritis and Rheumatism 51 (2021) Pag.858-874
  3. Toshihiko Shiga, Yuji Nozaki, Daisuke Tomita, Kazuya Kishimoto, Yasuaki Hirooka, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still’s Disease With/Without Macrophage Activation Syndrome from Other Secondary Hemophagocytic Lymphohistiocytosis in Adults. Frontiers in Immunology October 2021; Vol:12 Pag. 1-11.
  4. Sara Bindoli, Chiara Baggio, Andrea Doria, Paolo Sfriso. Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options. Drugs (2024) 84:257–274.
  5. Luana Andreea Macovei, Alexandra Burlui, Ioana Bratolu, Ciprian Rezus, Anca Cardoneanu, Patricia Richter, Andreea Szalontay, Elena Rezus. Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment. Int. J. Mol. Sci. 2022, 23, Pag. 1-26.
  6. Serena Colafrancesco, Maria Manara, Alessandra Bortoluzzi, Teodora Serban, Gerolamo Bianchi, Luca Cantarini, Francesco Ciccia, Lorenzo Dagna, Marcello Govoni, Carlomaurizio Montecucco, Roberta Priori, Angelo Ravelli, Paolo Sfriso, Luigi Sinigaglia, AOSD Consensus Group. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Res Ther 2019 Dec 11;21(1):275.
  7. Satoshi Suzuki, Yuko Kataoka, Tomoya Otani, Yukino Taniguchi, Keigo Ikeda, NaotoTamura, Shinji Morimoto. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature. Clinical rheumatology 2024 mar, 43(3) 1245.
  8. Shijia Rao. Lemuel Shui -Lun Tsang, Ming Zhao, Wei Shi , Qianjin Lu Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity front med (Lausana) 2022 9: 881431.
  9. Zhong-Bin Han, Ju Wu, Jing Liu, He-Ming LI, Kai Guo, Tong Sun. CASE REPORT Adult-onset Still's disease evolving with multiple organ failure and death: A case report and review of the literature. World Journal of Clinical Cases 2021 Vol 9(4): 886-897.
  10. Yoshifumi Tada, Akihito Maruyama, Yuri Shirahama. Still’s Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management. Drugs Aging (2024). https://doi.org/10.1007/s40266-024-01137-6
  11. Bruno Fautrel ,Stéphane Mitrovic, Arianna De Matteis, Sara Bindoli, Jordi Antón, Alexandre Belot, Claudia Bracaglia, Tamàs Constantin, Lorenzo Dagna, Alessandro Di Bartolo, Eugen Feist, Dirk Foell, Marco Gattorno, Sophie Georgin-Lavialle, Roberto Giacomelli, Alexei A Grom, Yvan Jamilloux, Katerina Laskari, Calin Lazar, Francesca Minoia, Peter A Nigrovic, Filipa Oliveira Ramos, Seza Ozen, Pierre Quartier, Piero Ruscitti, Erdal Sag, Sinisa Savic, Marie-Elise Truchetet, Sebastiaan J Vastert, Tanita-Christina Wilhelmer, Carine Wouters, Loreto Carmona, Fabrizio De Benedetti. EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult- onset Still’s disease Ann Rheum Dis 2024;83: 1614–1627. doi:10.1136/ard-2024-225851